The coexpression of the apoptosis-related genes bcl-2 and wt1 in predicting survival in adult acute myeloid leukemia
- 1 May 2002
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 16 (5), 846-854
- https://doi.org/10.1038/sj.leu.2402434
Abstract
The Wilms tumor gene wt1 and the protooncogene bcl-2 are upregulated in acute myeloid leukemia (AML) and are known to regulate or to inhibit the onset of apoptosis. Since wt1 has been shown to regulate the expression of bcl-2, we investigated the association of the expression of these genes and their prognostic relevance in AML. Leukemic blasts from the bone marrow of 152 patients with newly diagnosed AML were analyzed for bcl-2 and wt1 mRNA expression using RT-PCR and quantitative PCR. Therapy outcome was correlated with the level of bcl-2 and wt1 transcripts. Bcl-2-specific mRNA was detectable in 127/152 (84%) patients and wt1 mRNA in 113/152 (74%) patients with AML. In monocytic subtypes the frequency of bcl-2 and wt1 transcripts was significantly lower. The expression of bcl-2 mRNA was correlated significantly with that of wt1 mRNA (P < 0.0001). In AML patients 60 years, where the expression of bcl-2 or wt1 had no prognostic impact. Based on the coexpression of bcl-2 and wt1, we established a prognostic model defining three risk groups with significant differences in CCR rate (P = 0.01), overall survival (P < 0.04) and disease-free survival (P < 0.03). Thus, bcl-2 and wt1 mRNA expression are associated with response and long-term outcome in AMLs. The coexpression of these genes allows determination of prognostic groups with high predictive value for overall and disease-free survival.This publication has 34 references indexed in Scilit:
- E-cadherin Is a WT1 Target GeneOnline Journal of Public Health Informatics, 2000
- The Wilms Tumour GeneWT1in LeukaemiaLeukemia & Lymphoma, 1997
- The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCRAnnals of Oncology, 1995
- The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.Journal of Bone and Joint Surgery, 1995
- WT1-mediated Transcriptional Activation Is Inhibited by Dominant Negative Mutant ProteinsPublished by Elsevier BV ,1995
- WT-1 is required for early kidney developmentCell, 1993
- Alternative splicing and genomic structure of the Wilms tumor gene WT1.Proceedings of the National Academy of Sciences of the United States of America, 1991
- The candidate Wilms' tumour gene is involved in genitourinary developmentNature, 1990
- Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locusCell, 1990
- Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumpingNature, 1990